PD-1 immune checkpoint blockade can synergize with PSGL-1 inhibition to reinvigorate exhausted T cells

被引：0
|
作者：
Viramontes, Karla M. [1 ]
Neubert, Emily N. [1 ]
DeRogatis, Julia M. [1 ]
Henriquez, Monique [1 ]
Tinoco, Roberto [1 ]
机构：
[1] Univ Calif Irvine, Irvine, CA USA
来源：
JOURNAL OF IMMUNOLOGY | 2023年 / 210卷 / 01期
关键词：
D O I：
10.4049/jimmunol.210.Supp.59.23
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Predictive biomarkers for PD-1 and PD-L1 immune checkpoint blockade therapy
    Song, Yue
    Li, Zhaoming
    Xue, Weili
    Zhang, Mingzhi
    IMMUNOTHERAPY, 2019, 11 (06) : 515 - 529
  • [22] Enhancement of immune checkpoint PD-1 blockade efficacy in ovarian cancer
    Drakes, Maureen
    Mehrotra, Swati
    Potkul, Ronald
    Liu, Yueying
    Stack, M. Sharon
    Stiff, Patrick
    CANCER RESEARCH, 2018, 78 (13)
  • [23] Relapsing Polychondritis following PD-1 Blockade by an Immune Checkpoint Inhibitor
    Mutoh, Tomoyuki
    Chikamatsu, Sonoko
    Sasaki, Takatsuna
    Seino, Hiroto
    Sakamoto, Kazuhiro
    Kudo, Masataka
    JMA JOURNAL, 2023, 6 (04): : 552 - 555
  • [24] PD-1 expression by canine T cells and functional effects of PD-1 blockade
    Coy, J.
    Caldwell, A.
    Chow, L.
    Guth, A.
    Dow, S.
    VETERINARY AND COMPARATIVE ONCOLOGY, 2017, 15 (04) : 1487 - 1502
  • [25] PD-1 BLOCKADE-MEDIATED RESCUE OF EXHAUSTED T CELLS REQUIRES CD28
    Hui, E.
    Cheung, J.
    Zhu, J.
    Su, X.
    Taylor, M. J.
    Wallweber, H. A.
    Kamphorst, A. O.
    Wieland, A.
    Nasti, T.
    Yang, S.
    Zhang, R.
    Barber, D. L.
    CANCER DISCOVERY, 2017, 7 (05) : 453 - 453
  • [26] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Justin C. Moser
    Siwen Hu-Lieskovan
    Drugs, 2020, 80 : 459 - 465
  • [27] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [28] PD-1/PD-L1 checkpoint blockade in immune-antitumortherapy:advances and perspectives
    Yu LI
    Ji JIANG
    Bei HU
    中国药理学与毒理学杂志, 2017, 31 (10) : 963 - 963
  • [29] The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
    Mahoney, Kathleen M.
    Freeman, Gordon J.
    McDermott, David F.
    CLINICAL THERAPEUTICS, 2015, 37 (04) : 764 - 782
  • [30] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Moser, Justin C.
    Hu-Lieskovan, Siwen
    DRUGS, 2020, 80 (05) : 459 - 465
12345